Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Mounjaro does come with needles. Each KwikPen contains four pre-attached needle cannulas, one for each weekly dose, so you do not need to source separate needles for the pen itself. That said, understanding exactly what arrives in the box (and what good injection practice looks like) makes a real difference to how comfortable and consistent your treatment feels. Mounjaro (tirzepatide) is a prescription-only medicine, licensed in the UK for weight management in adults, which means a prescriber assesses your suitability before any treatment is dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people arrive at this question expecting something closer to an insulin pen, a separate vial, separate needles to attach, a dial to fill. Mounjaro works differently. The KwikPen is a self-contained, pre-filled device; tirzepatide comes loaded at the factory, and the needle mechanism is built in. You do not measure, draw up or attach anything before injecting.
Each pen delivers four weekly doses. Press the orange cap off, position the pen flat against your skin, and press the button. The needle inserts, the dose delivers, and the cannula retracts, all in one motion. For a closer look at how the pen functions in practice, the Mounjaro injection guide on this site walks through the steps in detail.
This design matters because a common worry is that injecting at home is technically difficult. For most people using the KwikPen, it isn't. If you are wondering whether the Mounjaro KwikPen comes with needles already included, the built-in needle and automatic retraction mean you focus on choosing the right spot and pressing a button, not on technique.
Inside a standard Mounjaro box you will find the KwikPen itself (containing four doses at the prescribed strength), the Patient Information Leaflet, and a Quick Start Guide from Eli Lilly. The needle cannulas are part of the pen assembly, they are not loose items rattling around in the packaging. Each cannula is single-use; after one injection, that needle section should not be reused, even for your next weekly dose from the same pen.
What is not included: a sharps container. You will need one for safe disposal. The sharps container available from our pharmacy is a practical option that meets UK clinical-waste requirements and fits in a kitchen drawer.
There are no alcohol swabs in the box, and the Mounjaro SmPC does not require you to clean the skin with one before every injection, though many people prefer to. If you do use swabs, let the skin dry fully before injecting.
The three licensed injection sites are the abdomen (at least 5 cm from the navel), the front of the thigh, and the outer upper arm. Rotating not just between sites but within them (a different patch of skin each week) keeps the tissue healthy and helps absorption stay consistent.
A quick checking habit that takes under a minute: before each injection, run a fingertip over the planned site. If the skin feels firm, lumpy or tender from a previous injection, move a few centimetres away. This simple check catches the early signs of lipohypertrophy (fatty tissue build-up) before it becomes a problem. There is more detail on site selection and technique in the guide to Mounjaro injection areas.
Injection-site reactions (mild redness, itching, or a small bruise) are listed among the more common side effects in the NHS tirzepatide medicines page. They usually settle quickly and rarely require changing the treatment. If a reaction seems severe or persists, the prescriber is the right first call.
Yes. Whether you are on 2.5 mg, 7.5 mg or 12.5 mg, the KwikPen format and the needle mechanism are the same. The pen does not change shape or size as your dose increases, only the concentration of tirzepatide inside differs. That consistency is useful, because the injection technique you learn at the start of treatment carries through every titration step.
Dose changes are decided by your prescriber, based on how your body responds and on clinical evidence. If you are exploring what the full treatment path looks like, the Mounjaro overview page covers the licensed UK dose schedule in context, and the background on Mounjaro's origins explains how the medicine is produced and supplied through the UK licensed supply chain. For context on how private treatment costs compare across the market, the overview of Eli Lilly's UK pricing changes is worth a read.
Mounjaro is a prescription-only medicine, so the route to treatment begins with a clinical assessment. If you would like a prescriber to review whether it is appropriate for you, you can check your eligibility through a free consultation with our team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.